Haitai Biotechnology Co., Ltd.

Legal opinion from Beijing Gaowen (Wuhan) Law Firm on the 2025 Annual General Meeting of Shareholders of the company

Announcement of resolutions from the 2025 Annual General Meeting of Shareholders

Announcement on obtaining the drug registration certificate for injectable isavuconazole

Announcement on the Resignation of a Director and Adjustment of Audit Committee Members

Announcement on the Resolutions of the Ninth Meeting of the Ninth Board of Directors

Announcement on the progress of concentrated bidding reduction of repurchased shares

Guotai Junan Securities Co., Ltd. on the Company's 2025 Annual Continuous Supervision Tracking Report

Guotai Junan Securities Co., Ltd. on the Verification Opinions of the Company's 2025 Annual Internal Control Self-evaluation Report

Guotai Junan Securities Co., Ltd. on the Special Verification Opinions on the Company's 2025 Annual Fund Storage, Management and Use

Guotai Junan Securities Co., Ltd. on the Regular On-site Inspection Report for the Second Half of 2025 Continuous Supervision Work

Disclosure Notice for the Q1 2026 Report

Disclosure Notice for the 2025 Annual Report

Announcement on the Proposed Reappointment of Accounting Firm

Independent Director's Work Report for 2025 (Zhou Haibing)

Independent Director's Work Report for 2025 (Ran Mingdong)

Independent Director's Work Report for 2025 (Mao Zongfu)

Announcement on the 2025 Online Performance Briefing

Internal Control Audit Report for the Year 2025

Internal Control Evaluation Report for the Year 2025

Remuneration Management System for Directors and Senior Management

Announcement on Changes in Accounting Policies

Goodwill Impairment Test Report for the Year 2025

Notice of the 2025 Annual Shareholders' Meeting

Work Report of the Board of Directors for the Year 2025

Announcement of Resolutions from the Eighth Meeting of the Ninth Board of Directors

Announcement on the Profit Distribution Plan for the Year 2025

Q1 2026 Report

Special Report on the Storage, Management, and Use of Raised Funds for the Year 2025 by the Board of Directors

Verification Report on the Annual Storage and Actual Use of Company Raised Funds by Zhongshen Zhonghuan Accounting Firm (Special General Partnership)

Special Verification Report from Zhongshen Zhonghuan Accounting Firm (Special General Partnership) on the Company's 2025 Operating Revenue Deduction Situation

Evaluation Report on the Performance of the Accounting Firm for 2025

Report from the Board of Directors' Audit Committee on the Accounting Firm's Performance of Supervision Responsibilities for 2025

Special Audit Report from Zhongshen Zhonghuan Accounting Firm (Special General Partnership) on the Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for 2025

Special Report on the Self-Examination of Independent Directors' Independence by the Board of Directors

2025 Annual Audit Report

2025 Annual Report

2025 Annual Report Summary

Announcement on Partial Share Pledge and Release of Pledge by the Controlling Shareholder

Announcement on the Progress of External Investment